San Antonio Breast Cancer Symposium, 2011

Anastrazole and Fulvestrant in Hormone Receptor-Positive Breast Cancer

SAN ANTONIO – Dr. William J. Gradishar and Dr. Hope S. Rugo, associate editors of The Oncology Report, discuss fulvestrant and anastrazole as first-line therapy for postmenopausal women with hormone receptor-positive breast cancer.

01/06/12

Submitting your vote...

Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

<- Back to: San Antonio Breast Cancer Symposium, 2011

I would like to receive The IMpulse E-Newsletter each week.

Specialty Focus

Sponsored by

Adolescent Medicine

Cardiology

Dermatology

Diabetes, Endocrinology & Metabolism

Oncology & Hematology

Practice Trends

Pulmonary Disease & Sleep Medicine

Rheumatology & Immunology

calendar

May 11 - 21 Departs Civitavecchia,	Rheumatology and Orthopaedics
May 11 - 21 Departs Civitavecchia,	Rheumatology and Orthopaedics
May 12 - 21 Departs Oslo,	Pain Management/Neurology/Compliance
May 18 - 23 San Francisco, CA	American Thoracic Society (ATS): International Conference
May 19 - 22 New York, NY	American Society of Hypertension (ASH): Annual Scientific Meeting
May 19 - 22 San Diego, CA	Digestive Disease Week (DDW 2012)
May 19 - 22 Sao Paulo,	XXX RADLA 2012: Annual Meeting of Latin American Dermatologists
May 19 - 24 Atlanta, GA	American Urological Association (AUA): Annual Meeting
May 19 - 23 Stockholm,	European Calcified Tissue Society (ECTS): Annual Congress
May 20 - 23 Brisbane,	Australasian College of Dermatologists: Annual Scientific Meeting

More Calendar »